Shedding Light on the Blood-Brain Barrier Transport with Two-Photon Microscopy In Vivo.
Krzysztof KucharzNikolay KutuzovOleg ZhukovMette Mathiesen JaniurekMartin Johannes LauritzenPublished in: Pharmaceutical research (2022)
Treatment of brain disorders relies on efficient delivery of therapeutics to the brain, which is hindered by the blood-brain barrier (BBB). The work of Prof. Margareta Hammarlund-Udenaes was instrumental in understanding the principles of drug delivery to the brain and developing new tools to study it. Here, we show how some of the concepts developed in her research can be translated to in vivo 2-photon microscopy (2PM) studies of the BBB. We primarily focus on the methods developed in our laboratory to characterize the paracellular diffusion, adsorptive-mediated transcytosis, and receptor-mediated transcytosis of drug nanocarriers at the microscale, illustrating how 2PM can deepen our understanding of the mechanisms of drug delivery to the brain.
Keyphrases
- drug delivery
- blood brain barrier
- resting state
- white matter
- cerebral ischemia
- functional connectivity
- cancer therapy
- particulate matter
- high resolution
- air pollution
- high speed
- optical coherence tomography
- drug release
- emergency department
- multiple sclerosis
- living cells
- risk assessment
- label free
- adverse drug
- water soluble
- single cell